Article: Neurogen Announces Positive Results for Proprietary Insomnia Drug in Two Chronic Insomnia Clinical Trials.(Financial report)

Article: Neurogen Commences Sleep Maintenance Phase II Clinical Trial in ...
PR Newswire;  December 20, 2006 ;     700+ words ... ... designed to measure sleep onset and maintenance in patients with chronic insomnia and this study ... In addition, sleep onset, as measured ... patients with chronic insomnia, aged up to 64 ... results for rapid sleep onset in our Phase II ... testing our drug in ...

Article: Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV ...
PR Newswire;  January 4, 2008 ;     700+ words ... ... improvement in sleep onset, sleep maintenance ... co-morbid chronic insomnia and generalized ... affected by chronic insomnia each year. Patients with chronic insomnia report higher ... difficulties with sleep onset and/or sleep ...

Article: Neurocrine Reports Positive Results for the First Indiplon Phase ...
PR Newswire;  February 18, 2004 ;     700+ words ... ... patients with chronic insomnia. Results of ... Latency to Sleep Onset (LSO) or the ... Wake After Sleep Onset (sWASO), and ... Awakenings After Sleep Onset (sNAASO) were ... patients with chronic insomnia who took indiplon ...

Article: Somaxon Pharmaceuticals, Inc. Initiates Second Phase III Clinical ...
Business Wire;  September 20, 2005 ;     700+ words ... ... SILENOR(TM) over a three month period in elderly patients diagnosed with primary chronic insomnia. The primary endpoint of the trial is Wake After Sleep Onset (WASO), the sleep maintenance endpoint recommended by the FDA. Multiple secondary ...

Article: Somaxon Pharmaceuticals Announces Positive Phase 3 Results with ...
PR Newswire;  April 10, 2006 ;     700+ words ... ... endpoint: Wake After Sleep Onset - Significant improvements ... results in adults with chronic insomnia. Results of the primary ... hour Wake After Sleep Onset (WASO), which is ... In patients with chronic insomnia, doxepin 3 mg and ...

Article: Somaxon Pharmaceuticals, Inc. Initiates Phase III Clinical Trials ...
Business Wire;  June 9, 2005 ;     700+ words ... ... SILENOR(TM) in adults with primary, chronic insomnia. The primary endpoint of the study ... sleep maintenance measure, Wake After Sleep Onset (WASO) measured by polysomnography ... induction measures such as Latency to Sleep Onset (LSO). About Somaxon Headquartered ...

Article: Polysomnographic Characteristics of Patients with Chronic ...
Sleep and Hypnosis;  October 1, 2004 ;     700+ words ... ... SDC) with chronic insomnia. Sixty-seven patients with chronic insomnia who underwent ... whole group, sleep onset latency was ... Measures such as sleep onset latency (SOL ... patients with chronic insomnia cannot be discarded ...